The present invention is directed to therapeutic agents of the formula (I) which are atypical antipsychotics and which arc useful in the treatment of neurological and psychiatric disorders associated with dopamine D2 and serotonin 5-HT2A neurotransmission dysfunction. wherein; R
申请公布号
AU2008236705(B2)
申请公布日期
2014.01.23
申请号
AU20080236705
申请日期
2008.04.03
申请人
MERCK SHARP & DOHME CORP.
发明人
NANDA, KAUSIK K.;BILODEAU, MARK T.;TROTTER, B. WESLEY
